Enveric Biosciences Inc vs ProShares UltraShort Bloomberg Natural Gas ETF — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while ProShares UltraShort Bloomberg Natural Gas ETF trades at $26.78. The key difference: ProShares UltraShort Bloomberg Natural Gas ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | KOLD | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $17.40 | $49.39 |
52-Week Low | $1.28 | $13.58 |
Enterprise Value | $408.82K | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
KOLD trades at $26.915, down 1.77% today, with technical indicators showing a bullish moving average signal but overbought RSI readings. The stock is influenced by natural gas market volatility, with recent news highlighting weather-driven demand shifts and record supply/demand forecasts for 2026. Support and resistance levels are tightly clustered around $25-$29, indicating potential for near-term price swings.
Outlook remains tactical, with KOLD serving as a leveraged tool for natural gas price movements. Key opportunities include geopolitical risks and LNG demand growth, while risks involve weather volatility and production increases. Analyst sentiment is mixed, emphasizing its role as a trading vehicle rather than a long-term hold.
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →KOLD is an inverse leveraged ETF that seeks to provide two times (2x) the inverse daily performance of the Bloomberg Natural Gas Subindex. It is designed for investors looking to profit from falling natural gas prices.
Read more on KOLD →